GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR
October 12, 2023 08:30 ET
|
GlucoTrack, Inc.
Rutherford, NJ, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock
April 13, 2023 09:22 ET
|
GlucoTrack, Inc.
Rutherford, NJ, April 13, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
GLUCOTRACK PROVIDES SHAREHOLDER UPDATE
March 14, 2023 10:00 ET
|
GlucoTrack, Inc.
Rutherford, NJ, March 14, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
Integrity Applications Announces Name Change to GlucoTrack, Inc.
November 29, 2021 08:30 ET
|
Integrity Applications, Inc.
Wilmington, DE and Or Yehuda, Israel,, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for...
Integrity Applications Provides Commercial Update
September 14, 2020 09:00 ET
|
Integrity Applications, Inc.
WILMINGTON, Del. and ASHDOD, Israel, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for...
Integrity Applications Receives CE Mark Approval for Self-Calibration Version of its GlucoTrack® Non-Invasive Glucose Monitoring Device
January 21, 2020 09:00 ET
|
Integrity Applications, Inc.
Major Milestone Simplifies Use and Opens Up Additional Sales and Distribution Channels Wilmington, DE and Ashdod, Israel, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Integrity Applications, Inc....